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Summary
A 129-day field study was conducted to
evaluate the effects of a clostridial bacterin-
toxoid administered subcutaneously at the base
of the ear on heifer calf performance,  surface-
ear temperature, and testosterone concentra-
tion. Two hundred previously non-implanted
heifers averaging 372 lb were assigned to one of
four treatments: 1) Alpha-7 (clostridial toxoid)
in left neck, Synovex-H in left ear (NL); 2)
Alpha-7 in left neck, Synovex-H in right ear
(NR); 3) Alpha-7 in right ear, Synovex-H in
opposite ear (OP); and 4) Alpha-7 in right ear,
Synovex-H in same ear (SM). On day 7, the
right ear of each heifer was thermographically
imaged. On trial days 7, 28, 59, and 87,  jugular
blood samples were collected to determine if
placement of the clostridial vaccine reduced
serum concentration of testosterone. Although
vaccinating in the base of the ear increased
(P<.01) ear temperature, daily gains through 59
days were similar (P$.44) for heifers injected in
the neck (NL + NR) vs those injected in the
base of the ear (SM + OP). Additionally, ear
temperature and animal performance were
similar (P$.11) for OP and SM placements of
vaccine and implant. Testosterone concentra-
tions were similar (P>.84) for heifers implanted
in the right ear and vaccinated in the same side
ear or neck.
(Key Words: Infrared, Injection Site, Growth
Implant, Heifers.)  
Introduction
Over the past 6 years, the beef industry has
encouraged the use of alternative injection sites
to reduce intramuscular injection-site blemishes
and has discouraged the development of prod-
ucts whose label requires intramuscular injec-
tion. In response to this issue, two clostridial
vaccines, Alpha-7® and Alpha-CD®, have
received FDA approval for  subcutaneous
administration in the base of the ear. Although
favorable immune responses are achieved with
an ear injection, placing an implant in the same
ear might alter the release characteristics. The
middle third of the ear is the only approved site
for placement of growth-promotant implants.
Identification tags and other biological
products targeted for placement at the base of
the ear also might have to be placed  in the
same ear as growth implants.  Sustained ab-
sorption of the active ingredients from the sur-
face of the implants is required, if they are to
improve carcass gain and feed efficiency. Local-
ized tissue reactions following vaccination or
antimicrobial usage might alter blood and lymph
drainage from the implant site.
Experimental Procedures
Two hundred forty eight heifers averaging
372 lbs were received from Mississippi in two
truckloads. Upon arrival, all heifers were
weighed individually, evaluated for abnormali-
ties, and  tagged in the left ear.
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Forty eight heifers were removed from the study
because of horns, abnormalities, and extreme
weights. The remaining heifers were allotted by
weight within truck load on the basis of unifor-
mity, breed type, frame size, body condition,
and health to one of the following four treat-
ments: 1) Alpha-7 (clostridial toxoid) in left
neck, Synovex-H in left ear (NL, N = 33); 2)
Alpha-7 in left neck, Synovex-H in right ear
(NR, N = 33); 3) Alpha-7 in right ear,
Synovex-H in opposite ear (OP, N = 67), and,
4) Alpha-7 in right ear, Synovex-H in same ear
(SM, N = 67). 
 
On the following day, each heifer received
a Fusion-4® (killed/modified live IBR, BVD,
PI3 and BRSV) and  Bar Somnus + 2P bact-
erin vaccination, a vitamin ADE injection, and a
mass medication with  Micotil® (as per label);
was wormed with Cydectin®; and was weighed
and branded. All heifers were vaccinated and
implanted according to treatment assignment on
day 0.  On day 7, all heifers were weighed
individually and the back of the right ear was
thermographically  imaged. Each ear was exam-
ined physically to assess the presence of im-
plants and any anatomical alteration at the site of
implantation and/or vaccination. Then a second
matching identification tag was placed in the
right ear. All heifers were weighed individually
on days 28, 56, 87, and 129 of the trial. On
days 7, 28, 59, and 87,  blood samples were
obtained (left jugular vein) for testosterone
analysis.
A one-way analysis of variance was used
initially to model the effects of treatment on ear
temperature, interim-weight, and daily-gain
variables. Orthogonal contrasts were used to
make direct comparisons of surface temperature
and animal performance be-
tween the different combinations of implant and
vaccine sites. This method was used to test: 1)
the null hypothesis of no difference between
neck (NL and NR) and ear (OP and SM)
vaccination, 2) vaccination in the neck and
implant in right vs. left ear (NL vs. NR), and 3)
vaccination in the right ear and implant in the
right vs. left ear (OP vs. SM).
Results and Discussion 
Heifers injected in the ear had higher ear
temperatures. No differences (P>.44)  with
regard to vaccination placement (neck vs. ear)
occurred in weight gain from 0 to 28, 29 to 59,
and 0 to 59 days.  However, over the entire
129-day period, heifers injected in the neck
gained faster (P=.02).  Although ear tempera-
tures were similar (P=.28) between the NL and
NR treatments, weight gain was greater (P<.04)
for calves implanted in the right ear (NR) over
all weigh periods. With vaccination in the ear,
ear temperature and growth performance were
similar (P>.11) for calves implanted in either the
left or right ear. We have no explanation for the
significant gain response for the NR treatment
relative to the other three treatments. 
All blood samples came from the left jugu-
lar.  Figure 1 shows that at all sampling times,
serum testosterone was higher for heifers with
the left ear implant (NL and OP vs NR and
SM). The similar testosterone concentrations
observed between treatments NR and SM
suggest that serum testosterone was not affected
by vaccination with Alpha-7 in the same ear as
the growth implant.  Serum testosterone values
peaked at 28 days post-implantation.  Implant-
ing and vaccinating in the same ear did not alter
performance when compared to implanting and
vaccinating in opposite ears.
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Table 1. Effect of Clostridium Bacterin-Toxoid Administered Subcutaneously at the Base
of the Ear on Calf Performance and Infrared Thermal Characteristics of the Ear
Treatments Contrasts
Item NL NR OP SM SE
Neck vs Ear
vacc
 (NL+NR)
vs (OP+SM)
Neck vacc site (L)
R vs L ear implant
(NL vs NR)
Ear vacc site (R)
R vs L ear implant
(OP vs SM)
Ear temp. °C 28.6 29.1 29.4 29.8 0.24 <.01 .28 .16
Wt gain 0-29 d 28 36 30 31 2.2 .44 .04 .46
Wt gain 29-59
d
50 61 52 57 2.9 .84 .03 .16
Wt gain 0-59 d 78 97 82 89 3.7 .49 <.01 .11
ADG, 129-d 1.63 1.87 1.64 1.66 0.04 .02 <.01 .64
Figure 1. Testosterone Levels in Heifers from Serum Collected on the Same Side (NL
and OP) or Opposite Side (NR and SM) from the Ear Bearing a Growth
Implant.
